Metformin | hsa00310 | Lysine degradation | 4.14E-02 | 1 | Q02809 | PLOD1 | More | |
Metformin | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.40E-02 | 1 | P50213 | IDH3A | More | |
Metformin | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | |
Metformin | hsa04550 | Signaling pathways regulating pluripotency of stem cells | 2.16E-02 | 2 | P04628, P40189 | WNT1, IL6ST | More | |
Metformin | hsa04613 | Neutrophil extracellular trap formation | 1.23E-03 | 5 | P11215, Q13547, P58876, Q16778, O60814 | ITGAM, HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | |
Metformin | hsa04630 | JAK-STAT signaling pathway | 3.09E-03 | 3 | O75925, P40189, Q06124 | PIAS1, IL6ST, PTPN11 | More | |
Metformin | hsa04920 | Adipocytokine signaling pathway | 4.76E-03 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | |
Metformin | hsa04931 | Insulin resistance | 1.48E-02 | 2 | Q06124, Q9Y478 | PTPN11, PRKAB1 | More | |
Metformin | hsa05034 | Alcoholism | 2.10E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | |
Metformin | hsa05202 | Transcriptional misregulation in cancer | 1.24E-02 | 4 | P27930, P11215, Q13547, P12980 | IL1R2, ITGAM, HDAC1, LYL1 | More | |
Metformin | hsa05203 | Viral carcinogenesis | 6.44E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | |
Metformin | hsa05226 | Gastric cancer | 2.94E-02 | 2 | P04628, P10826 | WNT1, RARB | More | |
Metformin | hsa05322 | Systemic lupus erythematosus | 1.18E-02 | 3 | P58876, Q16778, O60814 | H2BC5, HIST2H2BE, H2BC12 | More | |